Delivery Order SPE2DB24D2018-SPE2DB25FWUE1
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) for the supply of Varivax vaccine with diluents. The award, issued on July 7, 2025, with an ultimate completion date of July 28, 2025, carries a firm fixed price structure and represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,793.50 by the Defense Logistics Agency for Varivax vaccine with diluents. The contract, awarded on August 21, 2025, carries a firm fixed price structure with an ultimate completion date of September 12, 2025. This delivery order is classified as a child contract, indicating it derives from a larger indefinite delivery contract vehicle. No...
- The Defense Logistics Agency awarded a delivery order valued at $5,212.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $4,211.84 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is competitively awarded with no set-aside designation. The contract represents a child award under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $124.3K by the Defense Logistics Agency on September 3, 2025, with completion targeted for September 24, 2025. The contract calls for the supply of Varivax vaccine with diluents under a firm fixed-price arrangement. This is a non-set-aside award, indicating the contract was competitively awarded. The delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $41,284.40 for Varivax vaccine with diluents on April 28, 2025, with an ultimate completion date of May 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This award is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,159.03 on August 12, 2025, for the supply of Varivax vaccine with diluents. The order, which is non-competitive and carries a firm fixed price, is scheduled for completion by September 3, 2025, with performance to take place at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.33 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, operates under firm fixed-price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWUE1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of May 12, 2025, and utilizes no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp has demonstrated extensive capability in fulfilling DLA medical supply requirements across multiple therapeutic domains, including vaccines, specialty medications, brand-name and generic drugs, and related medical commodities. The company serves key federal customers including the Defense Health Agency and U.S. Coast Guard through its competitively awarded contracts with the DLA, positioning it as a primary vendor for military and veteran healthcare systems' pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/21/25 |